Ghost Fitness

Ghost Fitness/Omega-3/Is fish oil no longer recommended?

Is fish oil no longer recommended?

By George Thomas. Published 26 September 2026, updated 26 September 2026. Label figures and prices checked on the update date.

No: UK advice is unchanged, oily fish twice a week, with 250mg of EPA and DHA as the recognised stand-in. What deflated was megadose enthusiasm, after large outcome trials ran null and high doses showed a small atrial fibrillation signal.

  • Unchangedthe UK's fish-first advice and the authorised claims register
  • Nullthe big prevention trials' verdict on routine capsules in supplemented populations
  • Small AF signalwhat gram-scale dosing showed in the meta-analyses
  • 250mgthe modest daily territory that was never what deflated

The modest-dose position in product form: Futuro Labs Omega 3 Fish Oil on Amazon UK, 300mg EPA+DHA per softgel, £14.99 for 90 days. Label breakdown. The professional-practice angle is on do cardiologists recommend fish oil; the claim itself on omega-3 for heart health.

Where the no-longer-recommended story comes from

The headline has honest parents, and naming them dissolves most of the confusion. Through the 2010s, very large randomised trials, the VITAL trial the best known, tested whether routine fish oil capsules prevent heart attacks, strokes and cancer in general populations, and the primary results ran null, a genuine and important finding about a specific proposition: that adding capsules to modern, often fish-adequate, statin-era populations prevents disease. Alongside, the meta-analyses of gram-scale dosing, Gencer's Circulation analysis prominently, surfaced a small but consistent increase in atrial fibrillation risk at high doses, turning more-is-better into a claim with an actual cost. Journalism compressed both into fish oil doesn't work, and the supplement industry's own decades of overpromising, brain pills, joint cures, heart-attack prevention, had built the pedestal the fall was measured from. What fell was the megadose-prevention story. What the headlines rarely say is that the modest story was never on the pedestal.

What never changed, and the position that survives the trials intact

Three things stand exactly where they stood. The UK's food advice: two portions of fish weekly, one oily, from the SACN and toxicity committees' review, unmoved by capsule trials because it was never about capsules, and still the deepest-evidenced version of dietary omega-3. The claims register: EPA and DHA contribute to the normal function of the heart at 250mg daily, plus the DHA and quantified claims, all maintenance-of-normal wording that the null prevention trials do not touch, since maintaining normal function in an adequate intake sense and preventing cardiac events in a trial sense were always different propositions, which is precisely why the register's wording was written so carefully. And the nutritional logic underneath both: EPA and DHA are structural fats the diet must supply, oily fish is where they live, and a person who eats none has a genuine gap a modest supplement genuinely fills. The 2020s position is therefore not fish oil is dead but the pyramid the evidence always described: fish first, 250mg-scale capsules as the honest stand-in for non-fish-eaters, gram-scale dosing demoted to specific, medically-supervised jobs, and prevention promises retired.

The recommendation question, claim by claim
PropositionStatus after the trial eraVerdict
Eat oily fish twice a weekUnchanged UK adviceStill recommended: the anchor
250mg EPA+DHA daily as the fish stand-inClaims register unchangedStill recommended for non-fish-eaters
Routine capsules prevent heart attacksNull in the large trialsRetired: the story that deflated
More grams, more protectionSmall AF signal at high dosesRetired: high-dose is a supervised, specific tool
Prescription-grade EPA for specific lipid profilesA clinical optionAlive, inside cardiology, not the aisle
Fish oil for brains, joints, fat lossNever authorisedWas never recommended to begin with

The verdict, and the bottle that matches it

Is fish oil no longer recommended: the modest version is recommended exactly as before, the immodest version was the casualty, and the practical reading for a training life is unchanged from this section's pillar: eat the mackerel when you will, and when you will not, one honest softgel covers the authorised territory at pennies, Futuro Labs Omega 3 Fish Oil, 300mg of EPA and DHA with dinner, £14.99 for 90 days at 17p, lab-tested, UK made, sold on the claim that survived the decade rather than the ones that did not. Anyone with a heart condition, an arrhythmia history or a gram-scale plan takes the question to a GP, where the same trial era that wrote the headlines also wrote the guidance, and where fish oil never stopped being discussable, only stopped being magic.

What to check on the label

  • UK advice is unchanged: two fish portions weekly, one oily, remains the anchor.
  • The claims register is unchanged: 250mg maintenance territory stands.
  • What deflated: routine capsules as disease prevention: the big trials ran null.
  • High doses carry a small AF signal: gram-scale is now a supervised tool.
  • The honest position: fish first, modest softgel as the stand-in: promises retired.

The worked example: Futuro Labs Omega 3 Fish Oil

Futuro Labs Omega 3 Fish Oil: 1 softgel daily with food, 1000mg fish oil providing 180mg EPA and 120mg DHA (300mg combined), 90 softgels for £14.99, 17p a day, lab-tested purity, UK GMP made. Gelatin shell, so not vegetarian.

Fish oil per softgel
1000mg
EPA / DHA per softgel
180mg / 120mg (300mg combined)
Serving
1 softgel a day
Bottle
90 softgels, 90 days
Price
£14.99 (17p a day)
Softgel
mini softgel, no fishy taste
See it on Amazon UK Full label breakdown
Futuro Labs Omega 3 Fish Oil, 90 mini softgel bottle

Questions people also ask

Why do headlines say fish oil doesn't work?

They compress two real findings: null results for routine capsules preventing cardiac events in large trials, and a small atrial fibrillation signal at gram doses. Neither touches the modest 250mg maintenance territory or the fish-first advice.

Should I stop taking my daily fish oil softgel?

A 250mg-to-300mg softgel standing in for fish you do not eat is the version the evidence never deflated. Gram-scale routines are the ones worth a GP conversation.

Did the UK change its fish and omega-3 advice?

No: two portions weekly with one oily stands, and the authorised claims at 250mg stand with it.

Is high-dose fish oil dangerous now?

The meta-analyses show a small increased atrial fibrillation risk at gram-scale doses: not a panic, but a real cost that moves high-dose use into supervised territory.

What is fish oil actually still good for?

Supplying EPA and DHA a fish-free diet lacks, with the authorised maintenance claims at 250mg: the modest, honest job it always had underneath the marketing.

Sources

  1. Futuro Labs Omega 3 Fish Oil listing: 1000mg fish oil per softgel providing 180mg EPA and 120mg DHA, 90 softgels. Amazon UK, accessed 31 August 2026. https://www.amazon.co.uk/dp/B0CP9T3BTN
  2. Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (the VITAL randomized trial). New England Journal of Medicine 2019;380:23-33. PubMed record
  3. Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials: a systematic review and meta-analysis. Circulation 2021;144(25):1981-1990. PubMed record
  4. Scientific Advisory Committee on Nutrition and Committee on Toxicity. Advice on fish consumption: benefits and risks (two portions of fish a week, one oily). TSO, 2004. https://www.gov.uk/government/publications/sacn-advice-on-fish-consumption-benefits-and-risks
  5. EFSA Panel on Dietetic Products. Scientific opinion on the substantiation of health claims related to EPA and DHA and normal function of the heart (250mg daily condition of use). EFSA Journal 2010;8(10):1796. https://www.efsa.europa.eu/en/efsajournal/pub/1796
  6. EFSA Panel on Dietetic Products. Scientific opinion on the tolerable upper intake level of EPA, DHA and DPA: supplemental intakes of EPA and DHA combined up to about 5g/day do not raise safety concerns for adults. EFSA Journal 2012;10(7):2815. https://www.efsa.europa.eu/en/efsajournal/pub/2815